Excess costs of medical care for patients with diabetes in a managed care population

Diabetes Care

Volumn 20, Issue 9, 1997, Pages 1396-1402

  Selby, Joe V ^a   Ray, G Thomas ^a   Zhang, Danya ^b   Colby, Chris J ^a  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE;

EID: 0030764041     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.9.1396     Document Type: Article

References (23)

1. Huse DM, Oster G, Killen AR, Lacye MJ, Colditz GA: The economic costs of non-insulin-dependent diabetes mellitus. JAMA 262:2708-2713, 1989
2. Rubin RJ, Altman WM, Mendelson DN: Health care expenditures for people with diabetes mellitus. J Clin Endocrinol Metab 78:809A-812A, 1992
3. Aro S, Kangas T, Reunanen A, Salinto M, Koivisto V: Hospital use among diabetic patients and the general population. Diabetes Care 17:1320-1329, 1994
4. Schappert SM: Office Visits for Diabetes Mellitus: United States, 1989: Advance Data From Vital and Health Statistics (no. 211). Hyattsville, MD, National Center for Health Statistics, 1992
5. Glauber H, Brown J: Impact of cardiovascular disease on health care utilization in a defined diabetic population. J Clin Epidemiol 47:1133-1142, 1994
6. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
7. Reichard R Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
8. Ohkuba Y, Kishikawa H, Araki E: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
9. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Br Med J 285:685-688, 1982
10. Marre M, Chatellier G, Leblanc H, Guyenne TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297:1092-1095, 1988
11. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329:1456-1462, 1993
12. Hypertension Detection and Follow-up Program Cooperative Research Group: Mortality findings for stepped-care and referred-care participants in the Hypertension Detection and Follow-up Program, stratified by other risk factors. Prev Med 14:312-335, 1985
13. Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH: Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15:820-825, 1992
14. Runyan JW: The Memphis chronic disease program. JAMA 231:264-267, 1975
15. Davidson JK, Alogna M, Goldsmith M, Borden J: Assessment of program effectiveness at Grady Memorial Hospital, Atlanta. In Educating Diabetic Patients. Steiner G, Lawrence PA, Eds. New York, Springer-Verlag, 1981, p. 329-348
16. Diabetic Retinopathy Study Research Group: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81:383-396, 1976
17. Martin TL, Selby JV, Zhang D: Physician and patient prevention practices in NIDDM in a large urban managed-care organization. Diabetes Care 18:1124-1132, 1995
18. Hiatt RA, Friedman GD: Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health 72:829-833, 1982
19. Krieger N: Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82:703-710, 1992
20. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. In Diabetes, in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 47-68 (NIH publ. no. 95-1468)
21. Reaven GM: Role of insulin resistance in human disease (Banting Lecture). Diabetes 37:1595-1607, 1988
22. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NY Levin SR, Henderson W Lee HS, VA CSDM Group: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the feasibility trial. Diabetes Care 18:1113-1123 1995
23. Peters AL, Davidson MB: Management of patients with diabetes by nurses with support of subspecialists. HMO Pract 9:8-13, 1995